Renal-type clear cell carcinoma occurring in the prostate.

Am J Surg Pathol

Department of Urology, St. Luke's Episcopal Hospital, Houston, Texas, USA.

Published: March 2003

AI Article Synopsis

Article Abstract

Clear cell lesions of the urinary tract often present diagnostic challenges. We report a previously undescribed lesion in the prostate, occurring in a 73-year-old man who presented with hematuria and subsequently underwent transurethral resection of the prostate. A total of 24 g of tissue was removed, and in 4 of 17 blocks submitted a lesion morphologically and immunohistochemically similar to clear cell carcinoma of the kidney was noted. A thorough cystoscopic and full-body, radiologic workup was performed, but no renal tumor was discovered. Random cystoscopic biopsies of the bladder and prostatic urethra as well as bladder washings were benign. Subsequent needle biopsies of the prostate were also benign. The patient underwent a pelvic lymph node dissection with radical cystoprostatectomy and orthotopic Studer pouch diversion. There was organ-confined, ordinary-type prostatic adenocarcinoma (Gleason's 3 + 3) present bilaterally in the peripheral zone; no residual clear cell carcinoma was identified. All lymph nodes were negative, and the urinary bladder showed no dysplasia or neoplasia. We think this tumor represents a primary renal type of clear cell carcinoma arising in the prostate. To our knowledge, this type of tumor has not been previously reported to arise in an extrarenal location.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200303000-00016DOI Listing

Publication Analysis

Top Keywords

clear cell
20
cell carcinoma
16
cell
5
prostate
5
renal-type clear
4
carcinoma
4
carcinoma occurring
4
occurring prostate
4
clear
4
prostate clear
4

Similar Publications

Mycoplasma (Class: Mollicutes) contamination in cell cultures is a universal concern for research laboratories. Some estimates report contamination in up to 35% of continuous cell lines. Various commercial antibiotic treatments can successfully decontaminate clean cell lines ; however, decontamination of bacterial cultures remains challenging.

View Article and Find Full Text PDF

NKTCL is a highly aggressive malignant tumor, especially prevalent in the southern regions of China. Although chemotherapy regimens based on ADM have achieved certain therapeutic effects in early treatment, the issue of ADM resistance severely limits the therapeutic efficacy and makes it difficult to improve patient survival rates. Our research results indicate that the expression level of APOC1 is closely related to the sensitivity of NKTCL cells to ADM.

View Article and Find Full Text PDF

A new twist on superantigen-activated autoimmune disease.

J Clin Invest

January 2025

Division of Rheumatology, Center of Excellence for Intestinal and Immunology Research, University of Alberta, Edmonton, Alberta, Canada.

Superantigen-induced (Sag-induced) autoimmunity has been proposed as a mechanism for many human disorders, without a clear understanding of the potential triggers. In this issue of the JCI, McCarthy and colleagues used the SKG mouse model of rheumatoid arthritis to characterize the role of Sag activity in inflammatory arthritis by profiling arthritogenic naive CD4+ T cells. Within the diseased joints, they found a marked enrichment of T cell receptor-variable β (TCR-Vβ) subsets that were reactive to the endogenously encoded mouse mammary tumor virus (MMTV) Sag.

View Article and Find Full Text PDF

Introduction: Oxidative stress is an important cause of acetaminophen (APAP)-induced liver injury (AILI). Sakuranetin (Sak) is an antitoxin from the cherry flavonoid plant with good antioxidant effects. However, whether sakuranetine has a protective effect on APAP-induced liver injury is not clear.

View Article and Find Full Text PDF

In the past decade, the use of immune checkpoint therapy (ICT) has increased across many malignancies, including metastatic renal cell carcinoma as an option for frontline and subsequent lines of therapy. Despite the many therapeutic benefits of ICT, its use is complicated by the potential risk of immune-related adverse events (irAEs). One rare but potentially life-threatening irAE is hemophagocytic lymphohistiocytosis (HLH).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!